eXoZymes, Inc. (EXOZ) vs Lite Strategy, Inc. (LITS)
A side-by-side comparison of eXoZymes, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EXOZ
eXoZymes, Inc.
$5.60HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
LITS
Lite Strategy, Inc.
$1.42HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Total return — EXOZ vs LITS
growth of $100 · dividends reinvested · last 1yEXOZ -45.8% (-45.8%/yr)LITS -69.1% (-69.1%/yr)EXOZ compounded faster over this window
EXOZ LITS
EXOZ vs LITS: by the numbers
- •EXOZ is the larger company ($52M vs $48M market cap).
Metrics side by side
Valuation
| Metric | EXOZ | LITS |
|---|---|---|
| P/B ratio | 14.22 | 1.16 |
Profitability
| Metric | EXOZ | LITS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -278.89% | -170.94% |
| ROIC | -157.40% | -30.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.